|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/19 | (2006.01) |
| A61K 31/575 | (2013.01) | ||
| A61K 31/195 | (2006.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/185 | (2006.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 39/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3750531 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20169399.1 |
| Europos patento paraiškos padavimo data | 2014-02-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-09-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361804690 P | 2013-03-24 | US | |
| 201314140083 | 2013-12-24 | US |
| (72) |
COHEN,, Joshua B. , US
KLEE,, Justin , US
|
| (73) |
Amylyx Pharmaceuticals Inc. ,
43 Thorndike St, Cambridge, MA 02141,
US
|
| (54) | TUDCA AND SODIUM PHENYLBUTYRATE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| TUDCA AND SODIUM PHENYLBUTYRATE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |